SCHEMBL1562297

SCHEMBL1562297

Clc1nc(Cl)nc(NCc2ccccc2)n1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.59
PDE5A O76074 1/20 0.59
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
CA2 P00918 1/20 0.57
CA9 Q16790 1/20 0.57
CA14 Q9ULX7 1/20 0.57
KCNH3 Q9ULD8 1/20 0.56
LMNA P02545 3/20 0.56
NFKB1 P19838 1/20 0.53
RAD52 P43351 2/20 0.53
GAA P10253 2/20 0.51
PKM P14618 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
UBE2N P61088 1/20 0.51
KMT2A Q03164 1/20 0.51
RCE1 Q9Y256 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11788237 0.96 KCNH3 (0.61) APPPDE5ACA12CA1CA2
SCHEMBL10055023 0.89 CA9 (0.68) CA12CA1CA2CA9CA14
SCHEMBL20511399 0.89 CA12 (0.55) APPPDE5ACA12CA1CA2
SCHEMBL18276656 0.87 GAA (0.66) APPPDE5AGAANPSR1
SCHEMBL28736402 0.87 LMNA (0.60) APPPDE5ACA1CA2CA9
SCHEMBL5273353 0.84 LMNA (0.58) APPPDE5ACA12CA1CA2
SCHEMBL20511185 0.84 APP (0.48) APPPDE5ACA12CA1CA2
SCHEMBL3298289 0.84 KCNH3 (0.73) APPKCNH3LMNARAD52GAA
SCHEMBL11866701 0.83 CA12 (0.62) APPCA12CA1CA2CA9
SCHEMBL15720720 0.83 KCNH3 (0.56) APPPDE5ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827920-B2 Nanostructure, a biosensor including the nanostructure, and a screening method POSTECH Research and Business Development Foundation (KR) 2023-11-28 US disclosed
US-11827920-B2 Nanostructure, a biosensor including the nanostructure, and a screening method POSTECH Research and Business Development Foundation (KR) 2023-11-28 US disclosed
CN-108191774-B Heterocyclic compound, preparation method and application thereof 中国药科大学 2022-05-24 CN disclosed
WO-2020146779-A1 mTORC1 INHIBITORS FOR ACTIVATING AUTOPHAGY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-07-16 WO disclosed
WO-2018175958-A1 THIOREDOXIN MODULATORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2018-09-27 WO disclosed
US-20170020900-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF NIH - DEITR 2017-01-26 US disclosed
US-20170020900-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF NIH - DEITR 2017-01-26 US disclosed
US-9301940-B2 Methods for screening antimicrobial and antiviral compounds and uses thereof THE GENERAL HOSPITAL CORPORATION (US) 2016-04-05 US disclosed
US-9301940-B2 Methods for screening antimicrobial and antiviral compounds and uses thereof THE GENERAL HOSPITAL CORPORATION (US) 2016-04-05 US disclosed
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF UNIVERSITÀ DEGLI STUDI DI SIENA (IT) 2012-08-09 US disclosed
US-20080146518-A1 Cationic Lipids for the Transfection of Nucleic Acids POLITECNICO DI MILANO (IL) 2008-06-19 US disclosed
WO-2008066576-A2 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2008-06-05 WO disclosed
EP-1846378-A2 CATIONIC LIPIDS FOR THE TRANSFECTION OF NUCLEIC ACIDS Politecnico Di Milano (IT) 2007-10-24 EP disclosed
WO-2006087752-A2 CATIONIC LIPIDS FOR THE TRANSFECTION OF NUCLEIC ACIDS POLITECNICO DI MILANO (IT) 2006-08-24 WO disclosed
US-4981964-A PHOTOSTABILIZERS ICI AMERICAS INC. (US) 1991-01-01 US disclosed
EP-0373892-A1 Tetramethyl piperidyl terminated triazine oligomeric esters and amides ICI AMERICAS INC. (US) 1990-06-20 EP disclosed
EP-0373839-A1 Oligomeric polyesters and polyamides containing dipiperidyl triazine groups ICI AMERICAS INC. (US) 1990-06-20 EP disclosed
US-4889882-A RADIATION RESISTANCE, PHOTOSTABILITY POLYMER ADDITIVE ICI AMERICAS INC. (US) 1989-12-26 US disclosed
US-4874420-A Herbicidal substituted triazines BAYER AKTIENGESELLSCHAFT (DE) 1989-10-17 US disclosed
US-3931165-A INSECTICIDES, HERBICIDES BARER SOL J 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202814-A1 COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF DDX3X, DDX21, DDX39B APP 3458/4885PDE5A 1959/4885CA12 4168/4885
US-20170020900-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF ZC3HAV1, MAVS, EIF2AK2 APP 4366/4885PDE5A 3126/4885CA12 4842/4885
US-20080146518-A1 Cationic Lipids for the Transfection of Nucleic Acids AARS1, HARS1, LPAR3 APP 2852/4885PDE5A 4495/4885CA12 4624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.